欧洲癌症研究与治疗组织头颈癌生活质量模块EORTC QLQ-HN43修订版的国际验证:IV期研究
本研究纳入来自18个国家的812例头颈癌患者,对EORTC QLQ-HN43进行国际验证。组1在治疗前及治疗后3、6个月完成问卷,组2(幸存者)用于评估重测信度。结果显示10/12个多条目量表Cronbach's α>0.70,所有标准化因子负荷>0.40,除两个量表外ICC均>0.70,19个量表中有17个已知组差异>10分,18个量表对变化的敏感性充分,支持该模块的信度和效度。
要点
- EORTC QLQ-HN43在18国812例头颈癌患者中验证,10/12个多条目量表Cronbach's α>0.70。
- 所有标准化因子负荷>0.40,除两个量表外ICC均>0.70。
- 19个量表中有17个已知组差异>10分,18个量表对变化的敏感性充分。
核心结论
- 证据支持EORTC QLQ-HN43作为生活质量测量工具的信度和效度。
研究设计与样本
- IV期国际验证研究,纳入来自18个国家的812例头颈癌患者。
- 组1在治疗前及治疗后3、6个月完成问卷;组2为幸存者,用于评估重测信度。
主要发现
- 12个多条目量表中有10个Cronbach's α>0.70。
- 所有标准化因子负荷均>0.40。
- 除两个量表外,所有量表ICC均>0.70。
- 19个量表中有17个已知组间评分差异>10分。
- 18个量表对变化的敏感性充分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We validated the new European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43). METHODS: We enrolled 812 patients with head and neck cancer from 18 countries. Group 1 completed the questionnaire before therapy, and 3 and 6 months later. In group 2 (survivors), we determined test-retest reliability using intraclass correlation coefficients (ICC). Internal consistency was assessed using Cronbach's Alpha, the scale structure with confirmatory factor analysis, and discriminant validity with known-group comparisons. RESULTS: Cronbach's alpha was >0.70 in 10 of the 12 multi-item scales. All standardized factor loadings exceeded 0.40. The ICC was >0.70 in all but two scales. Differences in scale scores between known-groups were >10 points in 17 of the 19 scales. Sensitivity to change was found to be sufficient in 18 scales. CONCLUSIONS: Evidence supports the reliability and validity of the EORTC QLQ-HN43 as a measure of quality of life.
引用
- Singer S, Amdal CD, Hammerlid E, et al. International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Head Neck. 2019. PMID: 30636188. doi:10.1002/hed.25609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。